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GENERATION OF STIMULATED T BLASTS (EFFECTOR CELLS)
Isolated peripheral blood cells were incubated in 2 ml volumes (1 x 106 cells/well) in 24 well tissue culture plates (Cell Cult) at 370C, in 5% CO2 in air for seven days. PPD (Statens Seruminstitute, Denmark) at 10 ,ug/ml final concentration was added at the beginning of the culture period to generate antigen specific effector cells. Interleukin 2 stimulated cells were prepared as above except that 20 U/ml recombinant Interleukin 2 were added instead of PPD at the beginning of culture Interleukin 2 was used as a non-specific T cell stimulant.
SURFACE MARKER ANALYSIS
The surface phenotype of lymphoblast cultures stimulated by antigen for seven days was determined by a sensitive rosette assay using mono- We and others have previously shown that approximately 10% of the added mononuclear cells adhered as monocytes and this number was used to compute effector:target ratios in cytotoxicity assays.202' After six days' incubation, the non-adherent cells were washed offand the adherent cells incubated with antigen (PPD 25 ,ug/ml or streptokinase/streptodornase (SK/SD) 250 U/ml as control antigen and labelled with chromium-51 (2 ,uCi/well, CJS-1, Amersham International) overnight in a final volume of 100 ,ul. After 16-24 hours incubation the plates were washed three times with warm RPMI containing 5% heat inactivated, group A positive human serum after which the wells were replenished with 50 pl of RPMI containing 10% human serum.
CYTOTOXICITY ASSAY This method has been described in detail elsewhere.'820 Briefly, effector cells stimulated with antigen for seven days were harvested from the 24 well plates, washed once, and resuspended in RPMI supplemented with 10% human serum at 3 x 106/ml and7 5 x 10'/ml.
One hundred pl of these suspensions were added to target macrophages in triplicate to give effector:target ratios of approximately 20:1 and 5:1. Triplicate wells with 100 p1 of medium were used to determine spontaneous isotope release.
Some patients with tuberculosis were so profoundly lymphopenic that very low numbers of effector and target cells were available.
For these patients only one effector:target cell ratio was tested for each antigen combination.
After 18 hours' incubation the supernatant was aspirated from individual wells into counting tubes. One hundred ,l of 1% Triton X-100 (Sigma) were added to each cell pellet and incubated for 45 minutes at 60°C to lyse the remaining adherent cells. The entire volume was aspirated subsequently and transferred to further counting tubes. Activity of both the supernatant and pellet was assessed by measurement of radioactive decay with a gamma counter (LKB).
The percentage isotope release for each well was calculated by using the formula:
The level of cytotoxicity in each well was determined as follows: Cytotoxicity % isotope release in test well-% isotope release in spontaneous release well.
Results are presented as the mean (SD) of triplicate estimates of the percentage 51Cr release. The SD between triplicates was not normally greater than 5 %. Spontaneous release in these assays was usually no greater than 20% of the total uptake of isotope.
Cytolysis of macrophages which had not been incubated with antigen was termed nonspecific cytotoxicity. Cytolysis of macrophages incubated with PPD was termed antigen specific cytotoxicity.
MONOCLONAL ANTIBODY BLOCKING
The MHC restriction of PPD stimulated cells was determined by using antibodies directed against MHC class I (W6/32, A, B, C specific W6/32, SeraLab, UK) and class II (BU26, DP, DQ, DR specific, Dr M Goodall, Department of Immunology, Birmingham University) antigens. The antibodies were preincubated with target macrophages for 30 minutes before the addition of the effector cells and were present throughout the assay. LYMPHOCYTE Normal subjects and patients showed similar levels of non-specific lysis (lysis of antigen unpulsed macrophages), which ranged from 10 to 90% of the total lysis in both groups. Lysis of macrophages pulsed with control antigen (streptokinase/streptodornase) did not differ from that seen with unpulsed macrophages in either group. No relation was found between the ability to generate antigen specific or nonspecific cytotoxic T cells and age, sex, or race.
Interleukin 2 stimulated cells from Mantoux positive control subjects were only poorly cytotoxic to autologous antigen pulsed and unpulsed macrophages (figure 2), even though there was a good proliferative response to this cytokine (lymphocyte proliferation index > 80).
Proliferative responses to mycobacterial antigen were measured in 22 normal subjects and in 11 patients. There was a weak positive correlation between lymphocyte proliferation and cytolysis of antigen pulsed macrophages (r = 0 37, p > 0 04) (figure 3). phages pulsed with PPD were killed to a greater extent than those not pulsed with PPD (unpulsed) or macrophages pulsed with the control antigen streptokinase/streptodornase (p < 0 001 for all comparisons) in both groups.
PPD stimulated lymphocytes from normal BCG vaccinated subjects showed greater antigen specific cytolytic capacity than those from normal unvaccinated individuals (p < 0-001). PPD stimulated lymphocytes from patients with tuberculosis were less able to lyse PPD pulsed macrophages than those from normal BCG vaccinated subjects (p < 0 03). When patients were stratified according to clinical features, those with cavitating pulmonary disease and extrathoracic lymphadenopathy tended to generate higher amounts of antigen specific cytotoxicity than those with non-cavitatory pulmonary disease (p < 000 1). The Lymphocyte proliferation index 80 tion of 1:400 was 45% (p < 0 01) in patients and 65% (p < 0 001) in control subjects. In contrast, no significant blocking or a modest enhancement of cytolysis was observed when antibodies directed against class I determinants were used.
T CELL SUBSET DEPLETION PPD stimulated lymphocytes were depleted of CD4+ or CD8+ cells (as described in methods) and the depleted cell fraction was resuspended to give the final effector:target ratios indicated. Data pooled from four experiments are shown in figure 4 . These experiments used cells from normal donors since only a limited number of peripheral blood cells could be obtained from patients. Effector cells which were treated with ied magnetic beads alone (without antibody treating ment beforehand) were capable of lysing antigen pulsed or unpulsed target cells to the same extent as the unmanipulated fraction; thus, use of magnetic beads alone did not itself effect cytolysis. Depletion of CD4+ cells from PPD stimulated lymphocytes resulted in a decrease in antigen specific lysis of macrophages compared with unmanipulated or sham depleted fraction (p < 0 001 in each case). The residual killing of antigen pulsed targets by CD4 depleted cells was equivalent to that of unpulsed targets (p = 0940; figure 4) .
The effector cell fraction, which was depleted of CD8 bearing cells (and was therefore enriched for CD4+ cells), showed an enhanced ability to kill mycobacterial antigen bearing macrophage targets (p < 0 02).
Discussion
We have shown that the generation of sensitised CD4+ T cells can lyse autologous macroode phages presenting mycobacterial antigen, and is thus an integral part of the immune response to both BCG vaccination and infection with M 100 tuberculosis. This extends previous observations by ourselves and others.'61720 Although PPD) the patients with tuberculosis had significantly less ability to generate these cytolytic T cells of PPD than did BCG vaccinated subjects, the difference was a result of the relatively poor 32 Mononuclear cells in tuberculous granulomata show functional heterogeneity33 and tissue macrophages seem to possess significantly less antibacterial capacity than blood monocytes.34 It has been suggested consequently that cytolytic T cells may have a pivotal role in antimycobacterial immunity by releasing mycobacteria from the safe haven of poorly activated tissue macrophages so that they can be phagocytosed by the more active, blood derived monocytes. Extracellular mycobacteria would also be exposed to toxic macrophage products released from dying macrophages. Some support for this hypothesis is provided by the observation that reconstitution of cellular immunity in lepromatous leprosy lesions by intralesional interleukin 2 is associated with infiltration of CD4 and CD8 cells. There is subsequent lysis of parasitised macrophages within these lesions followed by rephagocytosis of the released bacilli by freshly migrated monocytes and a concomitant reduction in the bacterial count. '9 The finding of high levels of mycobacterialantigen specific, cytolytic T cells in certain groups of patients with tuberculosis strongly suggests that the ability to generate these cells does not equate with protective immunity. There was, however, a strong association of cytolytic activity and tissue destruction. All patients with pulmonary cavitation could generate significant amounts of cytolytic activity and high levels were also found in those with tuberculous lymphadenitis, many of whom formed cold abscesses that required open or closed drainage. It is notable that patients with pneumonic tuberculosis and miliary disease had a reduced capacity to generate mycobacterial-antigen specific, cytolytic T cells. We therefore suggest that in tuberculosis cytolytic T cells may be involved in delayed type hypersentivity and contribute to tissue destruction.
